| Term 
 
        | Drug Substance: Physiochemical Properties - Particle Size
 |  | Definition 
 
        | Physiologic Factors & Pt Characteristics - Gastric Emptying time
 |  | 
        |  | 
        
        | Term 
 
        | Drug Substance: Physiochem Properties - Crystalline or amorphous form
 |  | Definition 
 
        | Physiologic Factors & Pt Characteristics - Intestinal Transit Time
 |  | 
        |  | 
        
        | Term 
 
        | DS: Physiochem Props - Lipid/ Water solubility
 |  | Definition 
 
        | PF & PC Gastrointestinal abnormality/pathologic condtion
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dosage form chars: Disintegration rate
 |  | Definition 
 
        | drug metabolism (gut and first pass) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug metabolism (gut and first pass) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug metabolism (gut and first pass) |  | 
        |  | 
        
        | Term 
 
        | Pharmaceutical Excipients |  | Definition 
 
        | An excipient is a natural or synthetic substance formulated alongside the active ingredient of a medication, :1 included for the purpose of bulking-up formulations |  | 
        |  | 
        
        | Term 
 
        | Types of pharmaceutical Excipients |  | Definition 
 
        | Filler, binders, coatings, lubricants, surface active agents, disintegrating agents |  | 
        |  | 
        
        | Term 
 
        | Pulmonary Route of Administration |  | Definition 
 
        | Fast absorption, bypassing the liver. Drugs reach left atrium, ventricle and general circulation.
 Used for: bronchial diseases, antibiotics, mucolytic, beta-adrenergic mimetic, muscarinic receptor agonists.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Advantages: avoid intestinal and hepatic first-pass metabolism, fast absorption and to treat pulmonary diseases. Could be used for drugs like heparin and insulin. |  | 
        |  | 
        
        | Term 
 
        | Disadvantages for Pulmonary |  | Definition 
 
        | Large variability in dose delivery to alveoli, large variability in patient techniques for device utilization, narrow particle size distribution required for optimal therapeutic effect, anatomical barriers to reaching alveoli. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Intradermal: 10-15 degree angle SubQ: 45 degree angle
 Intramuscular: 90 degree angle
 |  | 
        |  |